Scholars Central

Conference abstractPublished 2022

Therapeutic potential of augmenting brain 2-arachidononyl glycerol in mild traumatic brain injury

Authors: Yumin Zhang

Uniformed Services University of the Health Sciences, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Mild traumatic brain injury (mTBI) is the major type of brain trauma and a risk factor for the late development of dementia and neurological diseases. Despite an increased understanding on the potential mechanisms of brain injury, there is still no effective treatment currently available. Using a repetitive mild traumatic brain injury (mTBI) mouse model, we found that treatment with MJN110, a novel inhibitor of the principal 2-arachidononyl glycerol (2-AG) hydrolytic enzyme monoacylglycerol lipase dose-dependently ameliorated the impaired locomotor function, learning and memory. Treatment with MJN110 reduced inflammatory response and normalize the expression of glutamate and GABA receptor components in the TBI mouse brain. Furthermore, treatment with MJN110 also alleviated post-traumatic headache, one of the common symptoms, by augmenting the 2-AG levels and reducing the production of calcitonin gene related peptides (CGRP) in the trigeminal system. The therapeutic effects of MJN110 were partially mediated by activation of CB1 and CB2 cannabinoid receptors and were eliminated when it was co-administered with DO34, a novel inhibitor of the 2-AG biosynthetic enzymes. Our results suggest that augmentation of the endogenous levels of 2-AG can be therapeutically useful in the treatment of TBI and its associated symptoms by suppressing neuroinflammation and normalizing neurotransmission.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neuroscience & Clinical Research
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Yumin Zhang”